Showing results (1-10 of 84) with videos related to
Sort By:
Pageof 9
Medizinische Monatsschrift Fur Pharmazeuten|June 29, 2018
Virus-free and cured? The “ART” of adherence. Current efficacy of anti-HIV therapyThomas HerdegenMolecular and Cellular Neurosciences|October 11, 2003
The concerted signaling of ERK1/2 and JNKs is essential for PC12 cell neuritogenesis and converges at the level of target proteinsVicki Waetzig, Thomas HerdegenMedizinische Monatsschrift Fur Pharmazeuten|April 25, 2006
[Drug safety of NSAIDs and COX-2 inhibitors]Thomas Herdegen, Joachim FaulerCurrent Drug Targets. CNS and Neurological Disorders|May 29, 2003
FK506 and its analogs - therapeutic potential for neurological disordersAlexa Klettner, Thomas HerdegenNeuroscience Letters|May 12, 2004
Neurodegenerative and physiological actions of c-Jun N-terminal kinases in the mammalian brainVicki Waetzig, Thomas HerdegenThe Journal of Biological Chemistry|October 29, 2002
A single c-Jun N-terminal kinase isoform (JNK3-p54) is an effector in both neuronal differentiation and cell deathVicki Waetzig, Thomas HerdegenScandinavian Journal of Pain|June 20, 2018
Long-term efficacy of spironolactone on pain, mood, and quality of life in women with fibromyalgia: An observational case seriesHeinrich Wernze, Thomas HerdegenMolecular and Cellular Neurosciences|March 18, 2009
Cerebral ischemia provokes a profound exchange of activated JNK isoforms in brain mitochondriaYi Zhao, Thomas HerdegenDeutsches Arzteblatt International|October 24, 2023
Drug Interactions of Tetrahydrocannabinol and Cannabidiol in Cannabinoid DrugsThomas Herdegen, Ingolf CascorbiPageof 9